# Yumanity Therapeutics Inc. (YMTX)

Source: https://www.quantisnow.com/company/YMTX
Generated: 2026-11-21T07:18:25.616Z

- Ticker: YMTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2016
- Website: yumanity.com

## About

Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. It focuses on discovering disease-modifying therapies to treat Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer's diseases. Its lead program is YTX-7739, a novel small molecule for the treatment of Parkinson's disease and related disorders of a-synuclein that is in Phase I clinical trial. The company is also developing YTX-9184 for the treatment of dementia with Lewy bodies. Yumanity Therapeutics Inc. has a strategic research and development collaboration agreement with Merck Sharp & Dohme Corp. The company is headquartered in Boston, Massachusetts.

## Latest YMTX news and filings

- 2024-02-14 20:40 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-yumanity-therapeutics-inc-5262571)
- 2024-02-12 21:05 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Yumanity Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-yumanity-therapeutics-inc-amendment-5250151)
- 2024-02-12 21:05 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Yumanity Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-yumanity-therapeutics-inc-amendment-5250142)
- 2024-01-17 13:30 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5190296)
- 2024-01-05 21:30 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5173439)
- 2023-12-15 13:30 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5139764)
- 2023-12-06 23:21 UTC [Insider Buy] [Bartoszek Raymond J. bought $9,950 worth of shares (2,250 units at $4.42), increasing direct ownership by 15% to 17,206 units (SEC Form 4)](https://www.quantisnow.com/insight/bartoszek-raymond-j-bought-9950-worth-of-shares-2250-units-5123394)
- 2023-11-30 22:27 UTC [Insider Buy] [Philips Craig W. bought $9,812 worth of shares (3,000 units at $3.27), increasing direct ownership by 5% to 60,811 units (SEC Form 4)](https://www.quantisnow.com/insight/philips-craig-w-bought-9812-worth-of-shares-3000-units-5112054)
- 2023-11-30 22:21 UTC [Insider Buy] [Iadonato Shawn bought $17,398 worth of shares (5,000 units at $3.48), increasing direct ownership by 0.75% to 675,230 units (SEC Form 4)](https://www.quantisnow.com/insight/iadonato-shawn-bought-17398-worth-of-shares-5000-units-at-5112039)
- 2023-11-15 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-yumanity-therapeutics-inc-5086006)
- 2023-11-13 22:28 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-yumanity-therapeutics-inc-5082035)
- 2023-11-06 13:30 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5060949)
- 2023-11-03 20:25 UTC [SEC Form S-3] [SEC Form S-3 filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-yumanity-therapeutics-inc-5059312)
- 2023-11-03 20:04 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-yumanity-therapeutics-inc-5058957)
- 2023-11-03 20:02 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5058894)
- 2023-11-03 20:01 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5058883)
- 2023-10-20 17:04 UTC [SEC Form D] [SEC Form D filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-yumanity-therapeutics-inc-5030531)
- 2023-10-17 12:32 UTC [SEC Form 8-K] [SEC Form 8-K filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-yumanity-therapeutics-inc-5023231)
- 2023-10-12 20:25 UTC [SEC Form 4] [Foote Marion R exercised 4,443 shares at a strike of $0.14, increasing direct ownership by 3% to 143,204 units (SEC Form 4)](https://www.quantisnow.com/insight/foote-marion-r-exercised-4443-shares-at-a-strike-of-5017871)
- 2023-10-05 20:05 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5007283)
- 2023-10-05 14:47 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-yumanity-therapeutics-inc-5006682)
- 2023-10-04 12:30 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5003356)
- 2023-10-03 12:30 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4999340)
- 2023-09-21 20:58 UTC [Insider Buy] [SEC Form 4: Philips Craig W. bought $8,495 worth of shares (3,500 units at $2.43), increasing direct ownership by 6% to 57,811 units](https://www.quantisnow.com/insight/sec-form-4-philips-craig-w-bought-8495-worth-of-4983119)
- 2023-09-21 20:57 UTC [Insider Buy] [SEC Form 4: Kenny Pauline bought $3,870 worth of shares (1,500 units at $2.58), increasing direct ownership by 9% to 18,448 units](https://www.quantisnow.com/insight/sec-form-4-kenny-pauline-bought-3870-worth-of-shares-4983116)
- 2023-09-21 20:57 UTC [Insider Buy] [SEC Form 4: Iadonato Shawn bought $25,042 worth of shares (10,000 units at $2.50), increasing direct ownership by 2% to 670,230 units](https://www.quantisnow.com/insight/sec-form-4-iadonato-shawn-bought-25042-worth-of-shares-4983114)
- 2023-09-21 20:56 UTC [Insider Buy] [SEC Form 4: Bartoszek Raymond J. bought $4,745 worth of shares (2,000 units at $2.37), increasing direct ownership by 15% to 14,956 units](https://www.quantisnow.com/insight/sec-form-4-bartoszek-raymond-j-bought-4745-worth-of-4983111)
- 2023-09-19 21:03 UTC [Insider Buy] [SEC Form 4: Baker Keith bought $10,672 worth of shares (5,000 units at $2.13), increasing direct ownership by 42% to 16,880 units](https://www.quantisnow.com/insight/sec-form-4-baker-keith-bought-10672-worth-of-shares-4978838)
- 2023-09-19 21:02 UTC [Insider Buy] [SEC Form 4: Bartoszek Raymond J. bought $6,290 worth of shares (3,000 units at $2.10), increasing direct ownership by 30% to 12,956 units](https://www.quantisnow.com/insight/sec-form-4-bartoszek-raymond-j-bought-6290-worth-of-4978830)
- 2023-09-15 22:49 UTC [SEC Form 4] [SEC Form 4: Guillaudeux Thierry bought $20,000 worth of shares (10,000 units at $2.00), increasing direct ownership by 85% to 21,696 units](https://www.quantisnow.com/insight/sec-form-4-guillaudeux-thierry-bought-20000-worth-of-shares-4974071)
- 2023-08-16 20:00 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-other-events-4907100)
- 2023-08-11 20:08 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-4885497)
- 2023-08-11 20:07 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Yumanity Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-yumanity-therapeutics-inc-4885470)
- 2023-08-11 20:03 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-results-of-operations-4885315)
- 2023-07-21 21:00 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-entry-into-a-4782351)
- 2023-07-05 20:19 UTC [SEC Form 4] [SEC Form 4 filed by Dylla Scott J.](https://www.quantisnow.com/insight/sec-form-4-filed-by-dylla-scott-j-4721174)
- 2023-07-05 20:18 UTC [SEC Form 4] [SEC Form 4 filed by Drapkin Kimberlee C](https://www.quantisnow.com/insight/sec-form-4-filed-by-drapkin-kimberlee-c-4721151)
- 2023-07-05 20:17 UTC [SEC Form 3] [SEC Form 3: New insider Dylla Scott J. claimed ownership of 4,000 shares](https://www.quantisnow.com/insight/sec-form-3-new-insider-dylla-scott-j-claimed-ownership-4721099)
- 2023-07-05 20:16 UTC [SEC Form 3] [SEC Form 3 filed by new insider Drapkin Kimberlee C](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-drapkin-kimberlee-c-4721078)
- 2023-07-03 13:31 UTC [SEC Form 8-K] [Yumanity Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/yumanity-therapeutics-inc-filed-sec-form-8-k-notice-of-delisting-4713379)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/YMTX
- Earnings history: https://www.quantisnow.com/earnings/YMTX
- Dividend history: https://www.quantisnow.com/dividends/YMTX
- Insider transactions: https://www.quantisnow.com/insiders/YMTX
- Options chain: https://www.quantisnow.com/options/YMTX
- SEC 8-K filings only: https://www.quantisnow.com/company/YMTX/8-k
- RSS and alerts for YMTX: https://www.quantisnow.com/docs/rss-feeds.md
